These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators. Colak Y; Yesil A; Mutlu HH; Caklili OT; Ulasoglu C; Senates E; Takir M; Kostek O; Yilmaz Y; Yilmaz Enc F; Tasan G; Tuncer I J Gastrointestin Liver Dis; 2014 Sep; 23(3):311-9. PubMed ID: 25267960 [TBL] [Abstract][Full Text] [Related]
23. Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats. Zhu W; Chen S; Chen R; Peng Z; Wan J; Wu B BMC Complement Altern Med; 2017 Sep; 17(1):455. PubMed ID: 28886741 [TBL] [Abstract][Full Text] [Related]
24. Effects of Eriobotrya japonica seed extract on oxidative stress in rats with non-alcoholic steatohepatitis. Yoshioka S; Hamada A; Jobu K; Yokota J; Onogawa M; Kyotani S; Miyamura M; Saibara T; Onishi S; Nishioka Y J Pharm Pharmacol; 2010 Feb; 62(2):241-6. PubMed ID: 20487204 [TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Musso G; Cassader M; Gambino R Nat Rev Drug Discov; 2016 Apr; 15(4):249-74. PubMed ID: 26794269 [TBL] [Abstract][Full Text] [Related]
26. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. Polanco-Briceno S; Glass D; Stuntz M; Caze A BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270 [TBL] [Abstract][Full Text] [Related]
27. Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitis. Eguchi A; Yoshitomi T; Lazic M; Johnson CD; Vong LB; Wree A; Povero D; Papouchado BG; Nagasaki Y; Feldstein AE Nanomedicine (Lond); 2015; 10(17):2697-708. PubMed ID: 26020857 [TBL] [Abstract][Full Text] [Related]
28. The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update. Sutti S; Bruzzì S; Albano E Expert Rev Gastroenterol Hepatol; 2016; 10(2):243-53. PubMed ID: 26634783 [TBL] [Abstract][Full Text] [Related]
29. INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. Leghi GE; Domenici FA; Vannucchi H Arq Gastroenterol; 2015; 52(3):228-33. PubMed ID: 26486292 [TBL] [Abstract][Full Text] [Related]
30. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915 [TBL] [Abstract][Full Text] [Related]
31. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. Jorgačević B; Mladenović D; Ninković M; Prokić V; Stanković MN; Aleksić V; Cerović I; Vukićević RJ; Vučević D; Stanković M; Radosavljević T Hum Exp Toxicol; 2014 Jul; 33(7):701-9. PubMed ID: 24130212 [TBL] [Abstract][Full Text] [Related]
32. Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease. Al Humayed S Arch Physiol Biochem; 2017 Feb; 123(1):23-30. PubMed ID: 27424611 [TBL] [Abstract][Full Text] [Related]
33. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management]. Spahr L; Hadengue A Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005 [TBL] [Abstract][Full Text] [Related]
34. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. Chen G; Ni Y; Nagata N; Xu L; Ota T Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875 [TBL] [Abstract][Full Text] [Related]
35. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice. Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833 [TBL] [Abstract][Full Text] [Related]
36. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation. Noori M; Jafari B; Hekmatdoost A J Sci Food Agric; 2017 Jun; 97(8):2327-2332. PubMed ID: 27717115 [TBL] [Abstract][Full Text] [Related]
37. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver. Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520 [TBL] [Abstract][Full Text] [Related]
38. Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis. Wree A; Mehal WZ; Feldstein AE Semin Liver Dis; 2016 Feb; 36(1):27-36. PubMed ID: 26870930 [TBL] [Abstract][Full Text] [Related]
39. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis. Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323 [TBL] [Abstract][Full Text] [Related]
40. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. Heeba GH; Morsy MA Environ Toxicol Pharmacol; 2015 Nov; 40(3):907-14. PubMed ID: 26498267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]